A Multiple Dose Study of BAY1834845 in Healthy Male Subjects and in Patients With Psoriasis

NCT03493269 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

72

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy Volunteers
Psoriasis

Interventions

DRUG: BAY1834845
OTHER: Matching Placebo
DRUG: Midazolam

Sponsor

Bayer